Growth Metrics

Item 9 Labs (INLB) Shares Outstanding (Diluted Average) (2021 - 2023)

Item 9 Labs' Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $100.6 million for Q2 2023.

  • For Q2 2023, Shares Outstanding (Diluted Average) rose 4.58% year-over-year to $100.6 million; the TTM value through Jun 2023 reached $100.6 million, up 4.58%, while the annual FY2022 figure was $95.7 million, 21.75% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $100.6 million in Q2 2023 per INLB's latest filing, down from $101.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $101.1 million in Q1 2023 to a low of $72.1 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 3 years is $91.8 million, with a median of $95.5 million recorded in 2022.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 33.35% in 2022 against a maximum downside of 4.47% in 2022.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $94.9 million in 2021, then grew by 4.47% to $99.2 million in 2022, then grew by 1.42% to $100.6 million in 2023.
  • Per Business Quant, the three most recent readings for INLB's Shares Outstanding (Diluted Average) are $100.6 million (Q2 2023), $101.1 million (Q1 2023), and $99.2 million (Q4 2022).